Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S4W-11624 · Session 4

Further to the answer to question S4W-10963 by Alex Neil on 29 November 2012, how many patients have been affected by the use of (a) off li…

Answered Asked by Dr Richard Simpson Lab Lodged 29 Nov 2012

The question

To ask the Scottish Government, further to the answer to question S4W-10963 by Alex Neil on 29 November 2012, how many patients have been affected by the use of (a) off licence and (b) unlicensed prescription medicines by the NHS in the last two years for which information is available.

The answer

Answered by Alex Neil on 13 Dec 2012 · 14 days after it was lodged, on time

As stated in my answer to question S4W-10963, medicine safety issues are subject matters of the Human Medicines Regulations 2012 and are currently reserved issues.
The Medicines and Healthcare products Regulatory Agency which is the UK government agency responsible for the regulation of medicinal products and medical devices, does collect information on adverse drug reactions, including those relating to off licence use, via their yellow card reporting system.
However, the system does not distinguish whether or not the medicine has been used on an unlicensed or off-label basis. Likewise, the NHS Information centre also has a system for collecting data, in their case from hospital admissions/episodes, and their system also does not distinguish between licensed and non-licensed use. Further information on the yellow card scheme is available at:
https://yellowcard.mhra.gov.uk.

In the Official Report

No contribution in the Official Report cites S4W-11624 by reference.